Acesso livre
Acesso livre

Arquivos do dia: Maio 26, 2022

Disponibilidade de recursos humanos para saúde e sua relação com a cobertura universal de saúde para 204 países e territórios de 1990 a 2019: análise sistemática para o Global Burden of Disease Study 2019.

26 Mai, 2022 | 13:33h

Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 – The Lancet

Comunicado de imprensa: Worldwide shortage of health workers threatens effective health coverage – Institute for Health Metrics and Evaluation

 

Comentários no Twitter

 

Estudo randomizado | Adição de metformina à terapia padrão não melhora os desfechos em pacientes com câncer de mama.

26 Mai, 2022 | 13:31h

Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial – JAMA (gratuito por tempo limitado)

Editorial: Who Will Benefit From Metformin? – JAMA Oncology

Comunicado de imprensa: Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals – Lunenfeld-Tanenbaum Research Institute

Estudo de coorte retrospectiva | A incidência de AVC isquêmico em pacientes com estenose carotídea grave assintomática (70 a 99%) sem intervenção cirúrgica foi de 4,7% ao longo de 5 anos.

26 Mai, 2022 | 13:29h

Incidence of Ischemic Stroke in Patients With Asymptomatic Severe Carotid Stenosis Without Surgical Intervention – JAMA (gratuito por tempo limitado)

Comunicado de imprensa: Low stroke risk in patients with very narrowed neck arteries – Kaiser Permanente

Diretriz de recomendação USPSTF | As evidências atuais são insuficientes para recomendar o rastreamento de glaucoma de ângulo aberto primário em adultos.

26 Mai, 2022 | 13:28h

Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement – JAMA

Editoriais:

Identifying Glaucoma in Primary Care Offices – JAMA Ophthalmology

Screening for Glaucoma – JAMA

Relatório de evidência: Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Página do paciente: Screening for Primary Open-Angle Glaucoma – JAMA

Entrevista com a autora: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults

Diretriz de recomendação USPSTF | As evidências atuais são insuficientes para recomendar o rastreamento de comprometimento da acuidade visual em idosos.

26 Mai, 2022 | 13:26h

Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement – JAMA

Editoriais:

Visual Acuity Screening in Older Adults – JAMA Ophthalmology

Screening for Impaired Visual Acuity in Older Adults – JAMA

Vision Impairment Has Implications for Aging and Health Outcomes, Beyond Ophthalmology – JAMA Network Open

Relatório de evidência: Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Página do paciente: Screening for Impaired Visual Acuity in Older Adults – JAMA

Entrevista com a autora: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults – JAMA

Efetividade da CoronaVac em crianças de 3 a 5 anos durante o surto da variante Ômicron do SARS-CoV-2 no Chile.

26 Mai, 2022 | 13:24h

Effectiveness of CoronaVac in children 3 to 5 years during the SARS-CoV-2 Omicron outbreak in Chile – Nature Medicine

Estudo randomizado | Baricitinibe vs. dexametasona para adultos internados com COVID-19.

26 Mai, 2022 | 13:23h

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial – The Lancet Respiratory Medicine

 

Comentário no Twitter

 

Efetividade relativa e de curto prazo de 4 doses vs. 3 doses de vacina BNT162b2 em pessoas com 60 anos de idade ou mais em Israel: estudo retrospectivo, de caso-controle teste negativo.

26 Mai, 2022 | 13:21h

Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study – The BMJ

Recomendações relacionadas:

Covid-19: Second boosters may benefit at-risk groups but have “minimal” impact for others, says WHO – The BMJ

COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines –
European Centre for Disease Prevention and Control

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals – U.S. Food & Drug Administration

Diretrizes de consenso sobre diagnóstico e tratamento da esofagite eosinofílica em crianças e adultos.

26 Mai, 2022 | 13:20h

British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults – Gut

Diretriz sobre lesão renal aguda associada a contraste.

26 Mai, 2022 | 13:18h

Canadian Association of Radiologists Guidance on Contrast Associated Acute Kidney Injury – Canadian Association of Radiologists Journal

Conteúdos relacionados:

Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation – Radiology

SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations—consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM) – La radiologia medica

Association of Intravenous Radiocontrast With Kidney Function: A Regression Discontinuity Analysis – JAMA Internal Medicine

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.